Characterization of AAV Vector Particle Stability at the Single-capsid Level
Overview
Authors
Affiliations
Virus families have evolved different strategies for genome uncoating, which are also followed by recombinant vectors. Vectors derived from adeno-associated viruses (AAV) are considered as leading delivery tools for in vivo gene transfer, and in particular gene therapy. Using a combination of atomic force microscopy (AFM), biochemical experiments, and physical modeling, we investigated here the physical properties and stability of AAV vector particles. We first compared the morphological properties of AAV vectors derived from two different serotypes (AAV8 and AAV9). Furthermore, we triggered ssDNA uncoating by incubating vector particles to increasing controlled temperatures. Our analyses, performed at the single-particle level, indicate that genome release can occur in vitro via two alternative pathways: either the capsid remains intact and ejects linearly the ssDNA molecule, or the capsid is ruptured, leaving ssDNA in a compact entangled conformation. The analysis of the length distributions of ejected genomes further revealed a two-step ejection behavior. We propose a kinetic model aimed at quantitatively describing the evolution of capsids and genomes along the different pathways, as a function of time and temperature. This model allows quantifying the relative stability of AAV8 and AAV9 particles.
Cavazza A, Molina-Estevez F, Plaza Reyes A, Ronco V, Naseem A, Malensek S Mol Ther Nucleic Acids. 2025; 36(1):102457.
PMID: 39991472 PMC: 11847086. DOI: 10.1016/j.omtn.2025.102457.
Formulation development and feasibility of AAV5 as a lyophilized drug product.
Vargas S, Sharifi F, Nambayan R, Moshashaee S, Siahaan T J Pharm Sci. 2025; 114(2):1214-1223.
PMID: 39827914 PMC: 11844822. DOI: 10.1016/j.xphs.2025.01.004.
Genome engineering with Cas9 and AAV repair templates, successes and pitfalls.
Birling M, Herault Y, Pavlovic G Mamm Genome. 2025; .
PMID: 39804466 DOI: 10.1007/s00335-024-10099-4.
Physicochemical and biological impacts of light stress on adeno-associated virus serotype 6.
Takino R, Yamaguchi Y, Maruno T, Ramadhani E, Furukawa M, Torisu T Mol Ther Methods Clin Dev. 2024; 32(4):101362.
PMID: 39624799 PMC: 11609365. DOI: 10.1016/j.omtm.2024.101362.
Therapeutic Application and Structural Features of Adeno-Associated Virus Vector.
Matsuzaka Y, Yashiro R Curr Issues Mol Biol. 2024; 46(8):8464-8498.
PMID: 39194716 PMC: 11353222. DOI: 10.3390/cimb46080499.